420 related articles for article (PubMed ID: 33149579)
1. Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
Thakur A; Sidu RK; Zou H; Alam MK; Yang M; Lee Y
Int J Nanomedicine; 2020; 15():8331-8343. PubMed ID: 33149579
[TBL] [Abstract][Full Text] [Related]
2. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
[TBL] [Abstract][Full Text] [Related]
4. Penetration of blood-brain barrier and antitumor activity and nerve repair in glioma by doxorubicin-loaded monosialoganglioside micelles system.
Zou D; Wang W; Lei D; Yin Y; Ren P; Chen J; Yin T; Wang B; Wang G; Wang Y
Int J Nanomedicine; 2017; 12():4879-4889. PubMed ID: 28744122
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles derived from dendritic cells loaded with VEGF-A siRNA and doxorubicin reduce glioma angiogenesis in vitro.
Shamshiripour P; Rahnama M; Nikoobakht M; Rad VF; Moradi AR; Ahmadvand D
J Control Release; 2024 May; 369():128-145. PubMed ID: 38522817
[TBL] [Abstract][Full Text] [Related]
6. c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma.
Huang Y; Liu W; Gao F; Fang X; Chen Y
Int J Nanomedicine; 2016; 11():1629-41. PubMed ID: 27143884
[TBL] [Abstract][Full Text] [Related]
7. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis.
Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation in vitro of doxorubicin loaded mimetic exosomes-based delivery system.
Suna He -; Haofeng Pan -; Xingyue Qian -; Junyang Zhang -; Runfang Zhang -
Pak J Pharm Sci; 2023 May; 36(3):895-900. PubMed ID: 37580940
[TBL] [Abstract][Full Text] [Related]
10. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
[TBL] [Abstract][Full Text] [Related]
11. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.
Li Y; Gao Y; Gong C; Wang Z; Xia Q; Gu F; Hu C; Zhang L; Guo H; Gao S
Nanomedicine; 2018 Oct; 14(7):1973-1985. PubMed ID: 29935333
[TBL] [Abstract][Full Text] [Related]
12. Transferrin-modified Doxorubicin-loaded biodegradable nanoparticles exhibit enhanced efficacy in treating brain glioma-bearing rats.
Liu G; Mao J; Jiang Z; Sun T; Hu Y; Jiang Z; Zhang C; Dong J; Huang Q; Lan Q
Cancer Biother Radiopharm; 2013 Nov; 28(9):691-6. PubMed ID: 23786401
[TBL] [Abstract][Full Text] [Related]
13. Angiopep-2-conjugated poly(ethylene glycol)-
Lu F; Pang Z; Zhao J; Jin K; Li H; Pang Q; Zhang L; Pang Z
Int J Nanomedicine; 2017; 12():2117-2127. PubMed ID: 28356732
[TBL] [Abstract][Full Text] [Related]
14. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
Ren J; Shen S; Wang D; Xi Z; Guo L; Pang Z; Qian Y; Sun X; Jiang X
Biomaterials; 2012 Apr; 33(11):3324-33. PubMed ID: 22281423
[TBL] [Abstract][Full Text] [Related]
15. Folic acid-decorated astrocytes-derived exosomes enhanced the effect of temozolomide against glioma.
Liu HM; Zhang Y
Kaohsiung J Med Sci; 2024 May; 40(5):435-444. PubMed ID: 38482902
[TBL] [Abstract][Full Text] [Related]
16. Environmentally Self-Adaptative Nanocarriers Suppress Glioma Proliferation and Stemness via Codelivery of shCD163 and Doxorubicin.
Liu J; Zhang Y; Chen T; Chen H; He H; Jin T; Wang J; Ke Y
ACS Appl Mater Interfaces; 2020 Nov; 12(47):52354-52369. PubMed ID: 33196179
[TBL] [Abstract][Full Text] [Related]
17. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Cui Y; Xu Q; Chow PK; Wang D; Wang CH
Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
[TBL] [Abstract][Full Text] [Related]
18. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
19. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
20. A novel peptide-drug conjugate for glioma-targeted drug delivery.
Zhou J; Meng N; Lu L; Lu J; Wu S; Ding Y; Wu S; Bao Y; Xu Q; Chen R; Wang J; Xie C; Wu J; Lu W
J Control Release; 2024 May; 369():722-733. PubMed ID: 38583575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]